Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study)

Objective: To assess effectiveness of 5-aminolevulinic acid (5-ALA, Gliolan®) in patients treated for malignant glioma under typical daily practice conditions in Spain, using complete resection rate (CR) and progression free survival at 6 months (PFS6). Materials and methods: Retrospective review of...

Full description

Bibliographic Details
Main Authors: R. Díez Valle, J. Slof, J. Galván, C. Arza, C. Romariz, C. Vidal
Format: Article
Language:English
Published: Elsevier España 2014-04-01
Series:Neurología (English Edition)
Online Access:http://www.sciencedirect.com/science/article/pii/S217358081400025X

Similar Items